Navigating CLL Treatment: Decoding Small-Molecule Inhibitor Sequencing and Combination Therapies

Deciphering the most effective treatment approach for chronic lymphocytic leukemia (CLL) has posed challenges due to limited data and the absence of long-term outcomes. This article examines and evaluates the current evidence for sequencing vs. combination of small-molecule inhibitors for CLL.